Portfolio Holdings Detail for ISIN IE00B14X4M10
Stock Name / FundiShares MSCI North America UCITS ETF USD (Dist) USD
IssuerBlackrock
Entity holding fund iShares Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300YDM1GFZR5B4U80
ETF TickerIDNA(USD) LSE
ETF TickerIQQN(EUR) F
ETF TickerIDNA.LS(USD) CXE
ETF TickerINAA.LS(GBX) CXE
ETF TickerINAA.MI(EUR) CXE
ETF TickerINAAz(USD) CXE
ETF TickerIQQN.DE(EUR) CXE
ETF TickerINAA(EUR) ETF Plus
ETF TickerIDNA.L(GBP) LSE

Holdings detail for ALNY

Stock NameAlnylam Pharmaceuticals Inc
TickerALNY(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS02043Q1076
LEI529900S3ZI14OWRJII50

Show aggregate ALNY holdings

News associated with ALNY

XBI, EXAS, ALNY, NTRA: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $288.7 million dollar outflow -- that's a 5.9% decrease week over week - 2025-05-09 14:52:51
Alnylam Pharmaceuticals (NASDAQ:ALNY) Trading 4% Higher Following Analyst Upgrade
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report)’s stock price was up 4% during mid-day trading on Monday after UBS Group raised their price target on the stock from $331.00 to $349.00. UBS Group currently has a buy rating on the stock. Alnylam Pharmaceuticals traded as high as $271.09 and last traded at $269.86. Approximately […] - 2025-05-07 05:24:42
Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Raised to $349.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price objective lifted by UBS Group from $331.00 to $349.00 in a research report sent to investors on Friday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. Several other equities research analysts have also commented on ALNY. Scotiabank upped their price objective on […] - 2025-05-05 07:25:01
Alnylam Pharmaceuticals (NASDAQ:ALNY) Cut to “Hold” at StockNews.com
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Wednesday. Other equities analysts have also recently issued research reports about the stock. Sanford C. Bernstein decreased their price objective on shares of Alnylam Pharmaceuticals from $314.00 to […] - 2025-05-02 05:16:49
These 3 Funds Offer Sky-High Yields of 15% or More and Trade at a Discount
My definition of a high yield is any yield at least twice the level of the S&P 500's yield. The threshold is currently around 2.56%. An ultra-high yield, in my view, is one that's four times higher than the S&P 500's yield. To reach that lofty level, a yield would need to - 2025-04-30 08:51:00
StockNews.com Upgrades Alnylam Pharmaceuticals (NASDAQ:ALNY) to “Buy”
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Tuesday. A number of other equities analysts have also weighed in on the stock. Citigroup boosted their price target on shares of Alnylam Pharmaceuticals […] - 2025-04-24 05:16:58
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives $315.58 Consensus PT from Brokerages
Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) have received a consensus rating of “Moderate Buy” from the twenty-six analysts that are presently covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell rating, four have given a hold rating and twenty-one have assigned a buy rating to the […] - 2025-04-18 05:44:49
Needham & Company LLC Reaffirms “Buy” Rating for Alnylam Pharmaceuticals (NASDAQ:ALNY)
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at Needham & Company LLC in a research note issued to investors on Wednesday,Benzinga reports. They currently have a $320.00 price target on the biopharmaceutical company’s stock. Needham & Company LLC’s price target would indicate a potential upside of […] - 2025-04-11 06:12:48
Corebridge Financial Inc. Has $520,000 Stock Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Corebridge Financial Inc. lessened its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 2.2% during the 4th quarter, HoldingsChannel reports. The fund owned 2,209 shares of the biopharmaceutical company’s stock after selling 50 shares during the quarter. Corebridge Financial Inc.’s holdings in Alnylam Pharmaceuticals were worth $520,000 at the end of […] - 2025-04-09 07:44:49
Top Analyst Reports for Broadcom, UnitedHealth & Toyota Motor
Today's Research Daily features new research reports on 16 major stocks, including Broadcom Inc. (AVGO), UnitedHealth Group Incorporated (UNH) and Toyota Motor Corporation (TM), as well as a micro-cap stock Perma-Pipe International Holdings, Inc. (PPIH). - 2025-04-04 20:54:00
Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Raised to $345.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) had its target price increased by Stifel Nicolaus from $300.00 to $345.00 in a report released on Monday,Benzinga reports. The firm presently has a “buy” rating on the biopharmaceutical company’s stock. Stifel Nicolaus’ price objective suggests a potential upside of 34.89% from the company’s previous close. A number […] - 2025-04-02 05:27:03
Alnylam Pharmaceuticals (NASDAQ:ALNY) Given New $342.00 Price Target at Scotiabank
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) had its target price upped by research analysts at Scotiabank from $338.00 to $342.00 in a report issued on Monday,Benzinga reports. The firm presently has a “sector outperform” rating on the biopharmaceutical company’s stock. Scotiabank’s target price would indicate a potential upside of 33.72% from the company’s previous […] - 2025-04-02 05:26:50
Incyte Stock: Is INCY Outperforming the Health Care Sector?
Incyte has outperformed the health care sector over the past year, and analysts are moderately optimistic about the stock’s prospects. - 2025-04-01 15:55:45
Stocks Recover Early Losses and Close Higher as Magnificent Seven Stocks Rebound
The S&P 500 Index ($SPX ) (SPY ) Friday closed up +0.08%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.39%. June E-mini S&P futures (ESM25 ) are up +0.08%, and June E-mini Nasdaq futures... - 2025-03-24 12:01:12
Natixis Advisors LLC Boosts Holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Natixis Advisors LLC grew its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 4.5% during the 4th quarter, HoldingsChannel reports. The fund owned 10,453 shares of the biopharmaceutical company’s stock after acquiring an additional 451 shares during the quarter. Natixis Advisors LLC’s holdings in Alnylam Pharmaceuticals were worth $2,460,000 at the […] - 2025-03-24 08:44:53
Needham & Company LLC Reaffirms “Buy” Rating for Alnylam Pharmaceuticals (NASDAQ:ALNY)
Needham & Company LLC reiterated their buy rating on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a research note released on Friday,Benzinga reports. The brokerage currently has a $320.00 price target on the biopharmaceutical company’s stock. A number of other research firms have also recently issued reports on ALNY. William Blair reissued an […] - 2025-03-24 07:00:43
Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Price Expected to Rise, Citigroup Analyst Says
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price objective upped by Citigroup from $338.00 to $351.00 in a research note released on Friday,Benzinga reports. The firm currently has a buy rating on the biopharmaceutical company’s stock. ALNY has been the topic of several other research reports. William Blair reiterated an “outperform” rating on shares […] - 2025-03-24 06:24:53
Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Raised to $390.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price target increased by Canaccord Genuity Group from $385.00 to $390.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a buy rating on the biopharmaceutical company’s stock. Several other equities research analysts have also issued reports on the company. Bank of America raised their […] - 2025-03-24 05:48:46
Royal Bank of Canada Increases Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $330.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price objective lifted by Royal Bank of Canada from $310.00 to $330.00 in a research report released on Friday morning,Benzinga reports. They currently have an outperform rating on the biopharmaceutical company’s stock. ALNY has been the subject of several other reports. StockNews.com downgraded shares of Alnylam Pharmaceuticals […] - 2025-03-24 05:48:44
Stocks Pare Losses as S&P 500 Looks for Weekly Win
The S&P 500 Index ($SPX ) (SPY ) today is down -0.31%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.20%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.18%. June E-mini S&P futures (ESM25 ) are down -0.28%, and June E-mini Nasdaq futures... - 2025-03-21 23:21:08
Weak Corporate Earnings Results Weigh on Stocks
The S&P 500 Index ($SPX ) (SPY ) today is down -0.81%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.95%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.97%. March E-mini S&P futures (ESH25 ) are down -0.84%, and March E-mini Nasdaq futures... - 2025-03-21 20:55:40
Stocks Fall on Disappointing Corporate Earnings and Economic Worries
The S&P 500 Index ($SPX ) (SPY ) today is down -0.54%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.62%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.53%. June E-mini S&P futures (ESM25 ) are down -0.50%, and June E-mini Nasdaq futures... - 2025-03-21 18:18:20
Friday's ETF Movers: XBI, COPX
In trading on Friday, the SPDR S&P Biotech ETF is outperforming other ETFs, up about 0.7% on the day. Components of that ETF showing particular strength include shares of Alnylam Pharmaceuticals, up about 13.1% and shares of Cytokinetics, up about 7.8% on the day. And unde - 2025-03-21 16:11:45
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Acquired by Atria Investments Inc
Atria Investments Inc increased its holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 5.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,311 shares of the biopharmaceutical company’s stock after acquiring an additional 166 shares during the quarter. Atria Investments Inc’s […] - 2025-03-14 09:52:58
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Shares Bought by Proficio Capital Partners LLC
Proficio Capital Partners LLC lifted its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 25,929.6% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 193,660 shares of the biopharmaceutical company’s stock after acquiring an additional 192,916 shares during the period. Alnylam Pharmaceuticals makes up approximately 0.6% of Proficio Capital Partners […] - 2025-03-14 09:05:23
USMV's Underlying Holdings Could Mean 11% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-03-10 11:43:47
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Position Lessened by Principal Financial Group Inc.
Principal Financial Group Inc. lowered its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 2.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 10,378 shares of the biopharmaceutical company’s stock after selling 230 shares during the quarter. Principal Financial Group Inc.’s holdings […] - 2025-03-06 10:01:07
New York Life Investment Management LLC Boosts Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
New York Life Investment Management LLC increased its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 6.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,384 shares of the biopharmaceutical company’s stock after buying an additional 153 shares during the period. […] - 2025-03-05 10:04:47
Brokerages Set Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) PT at $299.48
Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) have received a consensus rating of “Moderate Buy” from the twenty-five research firms that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and nineteen have issued a buy […] - 2025-02-27 06:53:09
Sanctuary Advisors LLC Boosts Stock Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Sanctuary Advisors LLC boosted its holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 7.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,915 shares of the biopharmaceutical company’s stock after purchasing an additional 357 shares during the period. Sanctuary […] - 2025-02-26 08:50:51

iShares MSCI North America UCITS ETF USD (Dist) USD ALNY holdings

DateNumber of ALNY Shares HeldBase Market Value of ALNY SharesLocal Market Value of ALNY SharesChange in ALNY Shares HeldChange in ALNY Base ValueCurrent Price per ALNY Share HeldPrevious Price per ALNY Share Held
2025-05-08 (Thursday)2,686USD 693,928USD 693,928
2025-05-07 (Wednesday)2,686USD 742,813USD 742,813
2025-05-06 (Tuesday)2,686USD 724,710ALNY holding decreased by -10045USD 724,7100USD -10,045 USD 269.81 USD 273.55
2025-05-05 (Monday)2,686USD 734,755ALNY holding increased by 38033USD 734,7550USD 38,033 USD 273.55 USD 259.39
2025-05-02 (Friday)2,686USD 696,722ALNY holding increased by 11443USD 696,7220USD 11,443 USD 259.39 USD 255.13
2025-05-01 (Thursday)2,686USD 685,279ALNY holding decreased by -21784USD 685,2790USD -21,784 USD 255.13 USD 263.24
2025-04-30 (Wednesday)2,686USD 707,063ALNY holding increased by 16251USD 707,0630USD 16,251 USD 263.24 USD 257.19
2025-04-29 (Tuesday)2,686USD 690,812ALNY holding increased by 6285USD 690,8120USD 6,285 USD 257.19 USD 254.85
2025-04-28 (Monday)2,686USD 684,527ALNY holding increased by 8837USD 684,5270USD 8,837 USD 254.85 USD 251.56
2025-04-25 (Friday)2,686USD 675,690ALNY holding increased by 24040USD 675,6900USD 24,040 USD 251.56 USD 242.61
2025-04-24 (Thursday)2,686USD 651,650ALNY holding increased by 1719USD 651,6500USD 1,719 USD 242.61 USD 241.97
2025-04-23 (Wednesday)2,686USD 649,931ALNY holding increased by 14020USD 649,9310USD 14,020 USD 241.97 USD 236.75
2025-04-22 (Tuesday)2,686ALNY holding decreased by -17USD 635,911ALNY holding increased by 6788USD 635,911-17USD 6,788 USD 236.75 USD 232.75
2025-04-21 (Monday)2,703USD 629,123ALNY holding decreased by -4893USD 629,1230USD -4,893 USD 232.75 USD 234.56
2025-04-18 (Friday)2,703USD 634,016USD 634,0160USD 0 USD 234.56 USD 234.56
2025-04-17 (Thursday)2,703USD 634,016ALNY holding increased by 10974USD 634,0160USD 10,974 USD 234.56 USD 230.5
2025-04-16 (Wednesday)2,703USD 623,042ALNY holding decreased by -1162USD 623,0420USD -1,162 USD 230.5 USD 230.93
2025-04-15 (Tuesday)2,703USD 624,204ALNY holding decreased by -24543USD 624,2040USD -24,543 USD 230.93 USD 240.01
2025-04-14 (Monday)2,703USD 648,747ALNY holding increased by 6055USD 648,7470USD 6,055 USD 240.01 USD 237.77
2025-04-11 (Friday)2,703USD 642,692ALNY holding increased by 31057USD 642,6920USD 31,057 USD 237.77 USD 226.28
2025-04-10 (Thursday)2,703USD 611,635ALNY holding decreased by -45924USD 611,6350USD -45,924 USD 226.28 USD 243.27
2025-04-09 (Wednesday)2,703USD 657,559ALNY holding increased by 51222USD 657,5590USD 51,222 USD 243.27 USD 224.32
2025-04-08 (Tuesday)2,703USD 606,337ALNY holding decreased by -23327USD 606,3370USD -23,327 USD 224.32 USD 232.95
2025-04-07 (Monday)2,703USD 629,664ALNY holding decreased by -7541USD 629,6640USD -7,541 USD 232.95 USD 235.74
2025-04-04 (Friday)2,703USD 637,205ALNY holding decreased by -84036USD 637,2050USD -84,036 USD 235.74 USD 266.83
2025-04-02 (Wednesday)2,703USD 721,241ALNY holding increased by 29922USD 721,2410USD 29,922 USD 266.83 USD 255.76
2025-04-01 (Tuesday)2,703USD 691,319ALNY holding decreased by -38545USD 691,3190USD -38,545 USD 255.76 USD 270.02
2025-03-31 (Monday)2,703USD 729,864ALNY holding increased by 4217USD 729,8640USD 4,217 USD 270.02 USD 268.46
2025-03-28 (Friday)2,703USD 725,647ALNY holding decreased by -6920USD 725,6470USD -6,920 USD 268.46 USD 271.02
2025-03-27 (Thursday)2,703USD 732,567ALNY holding increased by 4892USD 732,5670USD 4,892 USD 271.02 USD 269.21
2025-03-26 (Wednesday)2,703USD 727,675ALNY holding decreased by -31760USD 727,6750USD -31,760 USD 269.21 USD 280.96
2025-03-25 (Tuesday)2,703USD 759,435ALNY holding decreased by -26327USD 759,4350USD -26,327 USD 280.96 USD 290.7
2025-03-24 (Monday)2,703USD 785,762ALNY holding increased by 19894USD 785,7620USD 19,894 USD 290.7 USD 283.34
2025-03-21 (Friday)2,703USD 765,868ALNY holding increased by 80549USD 765,8680USD 80,549 USD 283.34 USD 253.54
2025-03-20 (Thursday)2,703USD 685,319ALNY holding increased by 271USD 685,3190USD 271 USD 253.54 USD 253.44
2025-03-19 (Wednesday)2,703USD 685,048ALNY holding increased by 24705USD 685,0480USD 24,705 USD 253.44 USD 244.3
2025-03-18 (Tuesday)2,703USD 660,343ALNY holding decreased by -23813USD 660,3430USD -23,813 USD 244.3 USD 253.11
2025-03-17 (Monday)2,703USD 684,156ALNY holding increased by 30679USD 684,1560USD 30,679 USD 253.11 USD 241.76
2025-03-14 (Friday)2,703USD 653,477ALNY holding increased by 27USD 653,4770USD 27 USD 241.76 USD 241.75
2025-03-13 (Thursday)2,703USD 653,450ALNY holding decreased by -1838USD 653,4500USD -1,838 USD 241.75 USD 242.43
2025-03-12 (Wednesday)2,703USD 655,288ALNY holding increased by 9974USD 655,2880USD 9,974 USD 242.43 USD 238.74
2025-03-11 (Tuesday)2,703USD 645,314ALNY holding increased by 15326USD 645,3140USD 15,326 USD 238.74 USD 233.07
2025-03-10 (Monday)2,703ALNY holding decreased by -17USD 629,988ALNY holding decreased by -35106USD 629,988-17USD -35,106 USD 233.07 USD 244.52
2025-03-07 (Friday)2,720ALNY holding decreased by -34USD 665,094ALNY holding decreased by -21285USD 665,094-34USD -21,285 USD 244.52 USD 249.23
2025-03-05 (Wednesday)2,754ALNY holding decreased by -170USD 686,379ALNY holding decreased by -23948USD 686,379-170USD -23,948 USD 249.23 USD 242.93
2025-03-04 (Tuesday)2,924ALNY holding decreased by -51USD 710,327ALNY holding decreased by -14175USD 710,327-51USD -14,175 USD 242.93 USD 243.53
2025-03-03 (Monday)2,975USD 724,502ALNY holding decreased by -9579USD 724,5020USD -9,579 USD 243.53 USD 246.75
2025-02-28 (Friday)2,975USD 734,081ALNY holding increased by 28708USD 734,0810USD 28,708 USD 246.75 USD 237.1
2025-02-27 (Thursday)2,975USD 705,373ALNY holding decreased by -20111USD 705,3730USD -20,111 USD 237.1 USD 243.86
2025-02-26 (Wednesday)2,975ALNY holding decreased by -17USD 725,484ALNY holding decreased by -8154USD 725,484-17USD -8,154 USD 243.86 USD 245.2
2025-02-25 (Tuesday)2,992USD 733,638ALNY holding decreased by -11190USD 733,6380USD -11,190 USD 245.2 USD 248.94
2025-02-24 (Monday)2,992USD 744,828ALNY holding decreased by -4937USD 744,8280USD -4,937 USD 248.94 USD 250.59
2025-02-21 (Friday)2,992ALNY holding increased by 17USD 749,765ALNY holding increased by 3040USD 749,76517USD 3,040 USD 250.59 USD 251
2025-02-20 (Thursday)2,975USD 746,725ALNY holding increased by 1458USD 746,7250USD 1,458 USD 251 USD 250.51
2025-02-19 (Wednesday)2,975USD 745,267ALNY holding increased by 1517USD 745,2670USD 1,517 USD 250.51 USD 250
2025-02-18 (Tuesday)2,975USD 743,750ALNY holding decreased by -19189USD 743,7500USD -19,189 USD 250 USD 256.45
2025-02-17 (Monday)2,975USD 762,939USD 762,9390USD 0 USD 256.45 USD 256.45
2025-02-14 (Friday)2,975USD 762,939ALNY holding decreased by -25109USD 762,9390USD -25,109 USD 256.45 USD 264.89
2025-02-13 (Thursday)2,975USD 788,048ALNY holding decreased by -3183USD 788,0480USD -3,183 USD 264.89 USD 265.96
2025-02-12 (Wednesday)2,975USD 791,231ALNY holding decreased by -9014USD 791,2310USD -9,014 USD 265.96 USD 268.99
2025-02-11 (Tuesday)2,975USD 800,245ALNY holding decreased by -15084USD 800,2450USD -15,084 USD 268.99 USD 274.06
2025-02-10 (Monday)2,975USD 815,329ALNY holding decreased by -6336USD 815,3290USD -6,336 USD 274.06 USD 276.19
2025-02-07 (Friday)2,975USD 821,665ALNY holding decreased by -6129USD 821,6650USD -6,129 USD 276.19 USD 278.25
2025-02-06 (Thursday)2,975USD 827,794ALNY holding increased by 5772USD 827,7940USD 5,772 USD 278.25 USD 276.31
2025-02-05 (Wednesday)2,975USD 822,022ALNY holding increased by 15797USD 822,0220USD 15,797 USD 276.31 USD 271
2025-02-04 (Tuesday)2,975USD 806,225ALNY holding decreased by -10561USD 806,2250USD -10,561 USD 271 USD 274.55
2025-02-03 (Monday)2,975USD 816,786ALNY holding increased by 9639USD 816,7860USD 9,639 USD 274.55 USD 271.31
2025-01-31 (Friday)2,975USD 807,147ALNY holding decreased by -17404USD 807,1470USD -17,404 USD 271.31 USD 277.16
2025-01-30 (Thursday)2,975USD 824,551ALNY holding increased by 9431USD 824,5510USD 9,431 USD 277.16 USD 273.99
2025-01-29 (Wednesday)2,975USD 815,120ALNY holding decreased by -15470USD 815,1200USD -15,470 USD 273.99 USD 279.19
2025-01-28 (Tuesday)2,975USD 830,590ALNY holding increased by 7318USD 830,5900USD 7,318 USD 279.19 USD 276.73
2025-01-27 (Monday)2,975USD 823,272ALNY holding decreased by -6039USD 823,2720USD -6,039 USD 276.73 USD 278.76
2025-01-24 (Friday)2,975USD 829,311ALNY holding increased by 9579USD 829,3110USD 9,579 USD 278.76 USD 275.54
2025-01-23 (Thursday)2,975USD 819,732ALNY holding increased by 26775USD 819,7320USD 26,775 USD 275.54 USD 266.54
2025-01-22 (Wednesday)2,975USD 792,957USD 792,957
2025-01-21 (Tuesday)2,975USD 788,345USD 788,345
2025-01-20 (Monday)2,975USD 732,653USD 732,653
2025-01-17 (Friday)2,975USD 732,653USD 732,653
2025-01-16 (Thursday)2,975USD 741,251USD 741,251
2025-01-15 (Wednesday)2,975USD 746,755USD 746,755
2025-01-14 (Tuesday)2,975USD 715,517USD 715,517
2025-01-13 (Monday)2,975USD 768,353USD 768,353
2025-01-10 (Friday)2,975USD 707,991USD 707,991
2025-01-09 (Thursday)2,975USD 715,636USD 715,636
2025-01-09 (Thursday)2,975USD 715,636USD 715,636
2025-01-09 (Thursday)2,975USD 715,636USD 715,636
2025-01-08 (Wednesday)2,975USD 715,636USD 715,636
2025-01-08 (Wednesday)2,975USD 715,636USD 715,636
2025-01-08 (Wednesday)2,975USD 715,636USD 715,636
2025-01-02 (Thursday)2,958ALNY holding increased by 85USD 691,048ALNY holding decreased by -38435USD 691,04885USD -38,435 USD 233.62 USD 253.91
2024-12-30 (Monday)2,958USD 698,118USD 698,118
2024-12-10 (Tuesday)2,873USD 729,483ALNY holding decreased by -5689USD 729,4830USD -5,689 USD 253.91 USD 255.89
2024-12-09 (Monday)2,873USD 735,172ALNY holding decreased by -1063USD 735,1720USD -1,063 USD 255.89 USD 256.26
2024-12-06 (Friday)2,873ALNY holding increased by 34USD 736,235ALNY holding increased by 21346USD 736,23534USD 21,346 USD 256.26 USD 251.81
2024-12-05 (Thursday)2,839USD 714,889ALNY holding decreased by -8261USD 714,8890USD -8,261 USD 251.81 USD 254.72
2024-12-04 (Wednesday)2,839USD 723,150ALNY holding increased by 8176USD 723,1500USD 8,176 USD 254.72 USD 251.84
2024-12-03 (Tuesday)2,839USD 714,974ALNY holding decreased by -3321USD 714,9740USD -3,321 USD 251.84 USD 253.01
2024-12-02 (Monday)2,839ALNY holding increased by 34USD 718,295ALNY holding increased by 8434USD 718,29534USD 8,434 USD 253.01 USD 253.07
2024-11-29 (Friday)2,805ALNY holding decreased by -34USD 709,861ALNY holding decreased by -10507USD 709,861-34USD -10,507 USD 253.07 USD 253.74
2024-11-28 (Thursday)2,839USD 720,368USD 720,3680USD 0 USD 253.74 USD 253.74
2024-11-27 (Wednesday)2,839USD 720,368ALNY holding increased by 1107USD 720,3680USD 1,107 USD 253.74 USD 253.35
2024-11-26 (Tuesday)2,839USD 719,261ALNY holding increased by 6729USD 719,2610USD 6,729 USD 253.35 USD 250.98
2024-11-25 (Monday)2,839USD 712,532ALNY holding increased by 17289USD 712,5320USD 17,289 USD 250.98 USD 244.89
2024-11-22 (Friday)2,839USD 695,243ALNY holding decreased by -5422USD 695,2430USD -5,422 USD 244.89 USD 246.8
2024-11-21 (Thursday)2,839USD 700,665ALNY holding decreased by -5650USD 700,6650USD -5,650 USD 246.8 USD 248.79
2024-11-20 (Wednesday)2,839USD 706,315ALNY holding increased by 41222USD 706,3150USD 41,222 USD 248.79 USD 234.27
2024-11-19 (Tuesday)2,839USD 665,093ALNY holding increased by 5678USD 665,0930USD 5,678 USD 234.27 USD 232.27
2024-11-18 (Monday)2,839USD 659,415ALNY holding decreased by -104134USD 659,4150USD -104,134 USD 232.27 USD 268.95
2024-11-12 (Tuesday)2,839ALNY holding increased by 68USD 763,549ALNY holding decreased by -5210USD 763,54968USD -5,210 USD 268.95 USD 277.43
2024-11-08 (Friday)2,771USD 768,759ALNY holding increased by 14437USD 768,7590USD 14,437 USD 277.43 USD 272.22
2024-11-07 (Thursday)2,771USD 754,322ALNY holding decreased by -2189USD 754,3220USD -2,189 USD 272.22 USD 273.01
2024-11-06 (Wednesday)2,771USD 756,511ALNY holding increased by 21392USD 756,5110USD 21,392 USD 273.01 USD 265.29
2024-11-05 (Tuesday)2,771USD 735,119ALNY holding decreased by -12912USD 735,1190USD -12,912 USD 265.29 USD 269.95
2024-11-04 (Monday)2,771USD 748,031ALNY holding decreased by -10974USD 748,0310USD -10,974 USD 269.95 USD 273.91
2024-11-01 (Friday)2,771USD 759,005ALNY holding increased by 20284USD 759,0050USD 20,284 USD 273.91 USD 266.59
2024-10-31 (Thursday)2,771USD 738,721ALNY holding decreased by -41288USD 738,7210USD -41,288 USD 266.59 USD 281.49
2024-10-30 (Wednesday)2,771USD 780,009ALNY holding decreased by -8867USD 780,0090USD -8,867 USD 281.49 USD 284.69
2024-10-29 (Tuesday)2,771USD 788,876ALNY holding decreased by -6152USD 788,8760USD -6,152 USD 284.69 USD 286.91
2024-10-28 (Monday)2,771USD 795,028ALNY holding increased by 5681USD 795,0280USD 5,681 USD 286.91 USD 284.86
2024-10-25 (Friday)2,771USD 789,347ALNY holding decreased by -24468USD 789,3470USD -24,468 USD 284.86 USD 293.69
2024-10-24 (Thursday)2,771USD 813,815ALNY holding decreased by -3270USD 813,8150USD -3,270 USD 293.69 USD 294.87
2024-10-23 (Wednesday)2,771USD 817,085ALNY holding decreased by -4461USD 817,0850USD -4,461 USD 294.87 USD 296.48
2024-10-22 (Tuesday)2,771USD 821,546ALNY holding increased by 12386USD 821,5460USD 12,386 USD 296.48 USD 292.01
2024-10-21 (Monday)2,771USD 809,160ALNY holding decreased by -10862USD 809,1600USD -10,862 USD 292.01 USD 295.93
2024-10-18 (Friday)2,771USD 820,022USD 820,022
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ALNY by Blackrock for IE00B14X4M10

Show aggregate share trades of ALNY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-04-22SELL-17 236.750* 258.18 Profit of 4,389 on sale
2025-03-10SELL-17 233.070* 262.54 Profit of 4,463 on sale
2025-03-07SELL-34 244.520* 262.82 Profit of 8,936 on sale
2025-03-05SELL-170 249.230* 263.04 Profit of 44,717 on sale
2025-03-04SELL-51 242.930* 263.36 Profit of 13,432 on sale
2025-02-26SELL-17 243.860* 264.78 Profit of 4,501 on sale
2025-02-21BUY17 250.590* 265.68
2025-01-02BUY85 233.620* 264.60
2024-12-06BUY34 256.260* 265.52
2024-12-02BUY34 253.010* 267.47
2024-11-29SELL-34 253.070* 268.05 Profit of 9,114 on sale
2024-11-12BUY68 268.950* 280.89
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ALNY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-05-09170,9551,137323,38652.9%
2025-05-08382,5811,581899,41642.5%
2025-05-07131,4462,828218,31160.2%
2025-05-06517,9117,413716,63772.3%
2025-05-05304,3563,848527,58957.7%
2025-05-02136,0073,773208,06965.4%
2025-05-01363,746490677,63553.7%
2025-04-30237,6844,832415,33857.2%
2025-04-29198,3895,983331,26759.9%
2025-04-28136,8421,137229,40759.7%
2025-04-25222,7761,993348,40763.9%
2025-04-24115,1631,767238,25748.3%
2025-04-23208,801464350,36459.6%
2025-04-22136,015231332,84940.9%
2025-04-21209,611603306,74268.3%
2025-04-17165,45174243,55867.9%
2025-04-16270,2943,357446,37060.6%
2025-04-15238,076403494,21648.2%
2025-04-14157,1483,912316,10849.7%
2025-04-11486,93714,123679,58371.7%
2025-04-10500,5972,591780,52664.1%
2025-04-09557,11511,336965,76057.7%
2025-04-08214,0941,301383,79455.8%
2025-04-07358,67932,038613,76358.4%
2025-04-04431,5561,025725,19559.5%
2025-04-03342,351477430,26279.6%
2025-04-02233,8961,506378,45961.8%
2025-04-01183,2658,200380,24848.2%
2025-03-31210,7774,770352,19159.8%
2025-03-28133,425181279,76547.7%
2025-03-27203,5676,557375,58354.2%
2025-03-26285,1751,249426,22666.9%
2025-03-25281,68810,979412,44068.3%
2025-03-24482,33425,397826,00858.4%
2025-03-21836,06628,3231,366,24861.2%
2025-03-20192,017151422,45045.5%
2025-03-19179,75963447,45240.2%
2025-03-18180,640478331,28254.5%
2025-03-17121,129153260,37646.5%
2025-03-14105,1308,747179,06158.7%
2025-03-1370,794138132,71653.3%
2025-03-12124,07084268,28746.2%
2025-03-11137,7132,010247,32355.7%
2025-03-1077,72466208,12337.3%
2025-03-07116,885207186,95062.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.